Mercury Pharmaceuticals UK

Sep 2026

First foods bring an early functional shift in the infant gut microbiome

Researchers analyzing paired gut microbiome samples from 125 Irish infants found that complementary feeding was associated with early changes in microbial composition and metabolic potential, including an increased capacity for complex carbohydrate metabolism. Breastfeeding duration was more closely associated with microbial community development than the timing of solid-food introduction, while formula-fed infants showed more extensive functional pathway changes after solids were introduced.

Sep 2026

Social media influencers shape memorable health messages for young adults

Emily Pfender, assistant professor in the department of communications at the University of Delaware, is a researcher on a new study in Health Communication.

Sep 2026

Breath test shows promise for identifying cancerous lung nodules

The human breath could help identify cancerous lung nodules negating the need for invasive testing.

Sep 2026

Forge Nano and Nanexa enter joint development agreement to advance manufacturing for ALD-coated PharmaShell® long-acting injectable medicines

Forge Nano, Inc., a leading U.S.-based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition ("ALD") technology for artificial intelligence ("AI")-era chip manufacturing and defense battery applications, which has signed an agreement to merge with Archimedes Tech SPAC Partners II Co. ("Archimedes II"), today announced a Joint Development Agreement ("JDA") with Nanexa AB to develop scalable pharmaceutical manufacturing capabilities for Nanexa's PharmaShell® drug delivery platform and its portfolio of proprietary and partnered programs.

Sep 2026

Sudden unexpected infant deaths drive widening Black-white mortality gap

After years of declines in sudden unexpected infant deaths (SUID), rates have been ticking up again, particularly among babies born to Black mothers, new research shows.

Sep 2026

Study finds oral hormone replacement therapy increases venous thromboembolism risk

Current use of oral menopausal hormone therapy (commonly known as hormone replacement therapy or HRT) is associated with an increased risk of blood clots in legs / lungs regardless of dose or treatment duration, finds a large Danish study published by The BMJ today.